DK0613499T3 - Humame IT-4-mutantproteiner - Google Patents

Humame IT-4-mutantproteiner

Info

Publication number
DK0613499T3
DK0613499T3 DK92923502T DK92923502T DK0613499T3 DK 0613499 T3 DK0613499 T3 DK 0613499T3 DK 92923502 T DK92923502 T DK 92923502T DK 92923502 T DK92923502 T DK 92923502T DK 0613499 T3 DK0613499 T3 DK 0613499T3
Authority
DK
Denmark
Prior art keywords
pct
date
human
mutant proteins
antagonists
Prior art date
Application number
DK92923502T
Other languages
English (en)
Other versions
DK0613499T4 (da
Inventor
Walter Prof Dr Sebald
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6444719&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0613499(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK0613499T3 publication Critical patent/DK0613499T3/da
Application granted granted Critical
Publication of DK0613499T4 publication Critical patent/DK0613499T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK92923502T 1991-11-13 1992-11-13 Humane IT-4-mutantproteiner DK0613499T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4137333A DE4137333A1 (de) 1991-11-13 1991-11-13 Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
PCT/EP1992/002614 WO1993010235A1 (de) 1991-11-13 1992-11-13 Menschliche il-4 mutantenproteine

Publications (2)

Publication Number Publication Date
DK0613499T3 true DK0613499T3 (da) 1998-09-23
DK0613499T4 DK0613499T4 (da) 2005-04-18

Family

ID=6444719

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92923502T DK0613499T4 (da) 1991-11-13 1992-11-13 Humane IT-4-mutantproteiner

Country Status (16)

Country Link
US (1) US5723118A (da)
EP (1) EP0613499B2 (da)
JP (2) JP3470970B2 (da)
KR (1) KR100276410B1 (da)
AT (1) ATE163196T1 (da)
AU (1) AU671960B2 (da)
CA (1) CA2123315C (da)
CZ (1) CZ283467B6 (da)
DE (2) DE4137333A1 (da)
DK (1) DK0613499T4 (da)
ES (1) ES2112340T5 (da)
GR (1) GR3026600T3 (da)
HU (1) HU217326B (da)
NO (1) NO312707B1 (da)
SK (1) SK280114B6 (da)
WO (1) WO1993010235A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4423131A1 (de) * 1994-07-01 1996-01-04 Bayer Ag Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
CA2196200A1 (en) * 1994-07-29 1996-02-15 Michael Joseph Browne Novel compounds
GB9415379D0 (en) * 1994-07-29 1994-09-21 Smithkline Beecham Plc Novel compounds
US5986059A (en) 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
AU725090B2 (en) * 1996-06-14 2000-10-05 Bayer Corporation T-cell selective interleukin-4 agonists
US6335426B1 (en) 1996-06-14 2002-01-01 Bayer Corporation T-cell selective interleukin-4 agonists
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins
US6180108B1 (en) * 1998-12-10 2001-01-30 Bayer Corporation Vectors having terminal repeat sequence of Epstein-Barr virus
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
ES2614260T3 (es) 2000-05-26 2017-05-30 Immunex Corporation Uso de anticuerpos contra el receptor de interleuquina-4 y composiciones de los mismos
GB0105360D0 (en) * 2001-03-03 2001-04-18 Glaxo Group Ltd Chimaeric immunogens
EP1314739A1 (en) * 2001-11-22 2003-05-28 Bayer Ag Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines
EP1382614A1 (en) * 2002-07-15 2004-01-21 Bayer HealthCare AG Process for the purification of interleukin-4 and its muteins
US7635754B2 (en) * 2004-09-22 2009-12-22 Aerovance, Inc. Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
US20070009479A1 (en) * 2005-06-17 2007-01-11 Aerovance, Inc. Methods for treating dermatitis using mutant human IL-4 compositions
JP2010514409A (ja) * 2006-06-21 2010-05-06 アポゲニクス ゲゼルシャフト ミット ベシュレンクテル ハフツング ヒトの癌における鑑別式サイトカイン発現
CA2656135A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human il-4 muteins in cancer therapy
EP2596802A1 (en) 2011-11-23 2013-05-29 PLS-Design GmbH Pharmaceutical composition for treatment of allergic reactions
EP2674168A1 (en) 2012-06-14 2013-12-18 PLS-Design GmbH Modulation of effector T cell responses by local depletion of complement component C3

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
KR900700132A (ko) * 1988-02-02 1990-08-11 에릭 에스. 딕커 면역 글로불린 e 반응 억제 방법
US5188827A (en) * 1989-12-18 1993-02-23 Schering Corporation Use of interleukin-4- for lowering blood-cholesterol levels

Also Published As

Publication number Publication date
GR3026600T3 (en) 1998-07-31
ES2112340T3 (es) 1998-04-01
DK0613499T4 (da) 2005-04-18
CZ283467B6 (cs) 1998-04-15
NO312707B1 (no) 2002-06-24
ATE163196T1 (de) 1998-02-15
NO941681L (no) 1994-05-06
AU2928292A (en) 1993-06-15
HU9401369D0 (en) 1994-08-29
CA2123315A1 (en) 1993-05-27
SK55494A3 (en) 1994-12-07
KR100276410B1 (ko) 2000-12-15
AU671960B2 (en) 1996-09-19
EP0613499B1 (de) 1998-02-11
NO941681D0 (no) 1994-05-06
ES2112340T5 (es) 2005-10-16
EP0613499A1 (de) 1994-09-07
SK280114B6 (sk) 1999-08-06
WO1993010235A1 (de) 1993-05-27
HUT66826A (en) 1995-01-30
DE4137333A1 (de) 1993-05-19
EP0613499B2 (de) 2005-03-30
DE59209196D1 (de) 1998-03-19
CZ118594A3 (en) 1994-12-15
HU217326B (hu) 1999-12-28
JP3470970B2 (ja) 2003-11-25
JPH07501522A (ja) 1995-02-16
JP2003174894A (ja) 2003-06-24
CA2123315C (en) 2003-06-17
US5723118A (en) 1998-03-03

Similar Documents

Publication Publication Date Title
DK0613499T3 (da) Humame IT-4-mutantproteiner
DE59507920D1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE69400799T2 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE179211T1 (de) Menschliche il-3-varianten
DE69226649D1 (de) Analoge des menschlichen Interleukin-8.
NO306345B1 (no) Piperidin-derivater med PAF antagonist-aktivitet, anvendelse derav og farmasöytisk blanding
ES2084149T3 (es) Conjugados de hirudinpolialquilenglicol.
ATE204021T1 (de) Klonierung, expression und charakterisierung einer neuen form der phosphatidylinositol-3- kinase
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
HUT68067A (en) Expression signal-peptide-free staphylokinases
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
MX9803791A (es) Intermediarios novedosos y su uso para preparar bisindolilmaleimidas n,n'-puenteadas.
NO305799B1 (no) Nye kinolinderivater, farmas°ytiske preparater inneholdende slike derivater, deres anvendelse samt mellomprodukter
FI952855A0 (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö